The State of Psychedelic Investing

The Green Market Report hosted a virtual event on May 12, 2021, titled, “The State of Psychedelic Investing.” The webinar was hosted by GMR CEO Debra Borchardt and featured Joel Bartch – CEO of Mydecine Innovations Group, Ronan Levy – Founder and CEO of Field Trip Health, and Simeon Schnapper – Founder of JLS Fund. These industry experts talked about managing investor expectations in the psychedelic industry. They also discussed the future of psychedelics and where they see the best opportunities. This is a recording of that event.

Video Staff

One comment

  • Faeleas Raingrove

    May 20, 2021 at 9:17 am

    nice video, 2020 marked the beginning of the psychedelics investment story as the capital markets fully embraced the alternative drug sector


Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

@GreenMarketRpt – 2 days

New Report from ⁦@headset_io⁩ Says Medical Cannabis Consumers Spend More. New story from ⁦@julsaitch⁩

@GreenMarketRpt – 2 days

Yowza. Be careful when investing in crowdfunding deals. SEC files complaint against CEO and others for…

Back to Top